Healthcare -
Biotechnology - NASDAQ - US
$ 2.615
1.36 %
$ 140 M
Market Cap
-2.75
P/E
TCRX - REVENUE
Revenue TCRX - TScan Therapeutics, Inc.
21 M
LAST VALUE
44.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR